Loading…

PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2

Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellular uptake; elimination of this drug can modulate...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2020-10, Vol.21 (19), p.7416
Main Authors: Freitas-Lima, Leandro Ceotto, Budu, Alexandre, Arruda, Adriano Cleis, Perilhão, Mauro Sérgio, Barrera-Chimal, Jonatan, Araujo, Ronaldo Carvalho, Estrela, Gabriel Rufino
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533
cites cdi_FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533
container_end_page
container_issue 19
container_start_page 7416
container_title International journal of molecular sciences
container_volume 21
creator Freitas-Lima, Leandro Ceotto
Budu, Alexandre
Arruda, Adriano Cleis
Perilhão, Mauro Sérgio
Barrera-Chimal, Jonatan
Araujo, Ronaldo Carvalho
Estrela, Gabriel Rufino
description Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellular uptake; elimination of this drug can modulate renal damage. Organic transporters play an important role in the transport of cisplatin into the kidney and organic cations transporter 2 (OCT-2) has been shown to be one of the most important transporters to play this role. On the other hand, multidrug and toxin extrusion 1 (MATE-1) transporter is the main protein that mediates the extrusion of cisplatin into the urine. Cisplatin nephrotoxicity has been shown to be enhanced by increased OCT-2 and/or reduced MATE-1 activity. Peroxisome proliferator-activated receptor alpha (PPAR-α) is the transcription factor which controls lipid metabolism and glucose homeostasis; it is highly expressed in the kidneys and interacts with both MATE-1 and OCT-2. Considering the above, we treated wild-type and PPAR-α knockout mice with cisplatin in order to evaluate the severity of nephrotoxicity. Cisplatin induced renal dysfunction, renal inflammation, apoptosis and tubular injury in wild-type mice, whereas PPAR-α deletion protected against these alterations. Moreover, we observed that cisplatin induced down-regulation of organic transporters MATE-1 and OCT-2 and that PPAR-α deletion restored the expression of these transporters. In addition, PPAR-α knockout mice at basal state showed increased MATE-1 expression and reduced OCT-2 levels. Here, we show for the first time that PPAR-α deletion protects against cisplatin nephrotoxicity and that this protection is via modulation of the organic transporters MATE-1 and OCT-2.
doi_str_mv 10.3390/ijms21197416
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7582648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2548688689</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533</originalsourceid><addsrcrecordid>eNpVkdtq3DAQhkVpaI53vS6C3taJjpZ1E1i2mwNkuyH4Xsi2vNHilRxJLt3HyovkmeJkk2ULAzPwf_wzww_Ad4zOKZXowq7WkWAsBcP5F3CEGSEZQrn4ujcfguMYVwgRSrj8Bg4pRUxKKY6Au7-fPGQvz_C36Uyy3sFJSsYNOpkIpzb2nU7WwT-mfww--X-2tmkDqw2c-2Z415bwwTjdwUVYamdrWAbtYu9DMiHC-aScZRhq18DFtMzIKThodRfN2Uc_AeXVrJzeZHeL69vp5C6rGSYpE01lWiY4kryuKiy5MZxh1FKBBeWFlA0pasFyxFjOqTZFjmhbSZrzgjFO6Qm43Nr2Q7U2TW1cCrpTfbBrHTbKa6v-V5x9VEv_VwlekJwVo8HPD4PgnwYTk1r5IYxvRkU4K_JiLDlSv7ZUHXyMwbS7DRipt3DUfjgj_mP_qh38mQZ9BeQBiwE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548688689</pqid></control><display><type>article</type><title>PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Freitas-Lima, Leandro Ceotto ; Budu, Alexandre ; Arruda, Adriano Cleis ; Perilhão, Mauro Sérgio ; Barrera-Chimal, Jonatan ; Araujo, Ronaldo Carvalho ; Estrela, Gabriel Rufino</creator><creatorcontrib>Freitas-Lima, Leandro Ceotto ; Budu, Alexandre ; Arruda, Adriano Cleis ; Perilhão, Mauro Sérgio ; Barrera-Chimal, Jonatan ; Araujo, Ronaldo Carvalho ; Estrela, Gabriel Rufino</creatorcontrib><description>Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellular uptake; elimination of this drug can modulate renal damage. Organic transporters play an important role in the transport of cisplatin into the kidney and organic cations transporter 2 (OCT-2) has been shown to be one of the most important transporters to play this role. On the other hand, multidrug and toxin extrusion 1 (MATE-1) transporter is the main protein that mediates the extrusion of cisplatin into the urine. Cisplatin nephrotoxicity has been shown to be enhanced by increased OCT-2 and/or reduced MATE-1 activity. Peroxisome proliferator-activated receptor alpha (PPAR-α) is the transcription factor which controls lipid metabolism and glucose homeostasis; it is highly expressed in the kidneys and interacts with both MATE-1 and OCT-2. Considering the above, we treated wild-type and PPAR-α knockout mice with cisplatin in order to evaluate the severity of nephrotoxicity. Cisplatin induced renal dysfunction, renal inflammation, apoptosis and tubular injury in wild-type mice, whereas PPAR-α deletion protected against these alterations. Moreover, we observed that cisplatin induced down-regulation of organic transporters MATE-1 and OCT-2 and that PPAR-α deletion restored the expression of these transporters. In addition, PPAR-α knockout mice at basal state showed increased MATE-1 expression and reduced OCT-2 levels. Here, we show for the first time that PPAR-α deletion protects against cisplatin nephrotoxicity and that this protection is via modulation of the organic transporters MATE-1 and OCT-2.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21197416</identifier><identifier>PMID: 33049997</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Ablation ; Animals ; Antineoplastic Agents - adverse effects ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - genetics ; Binding sites ; Biomarkers ; Cations ; Chemotherapy ; Cisplatin ; Cisplatin - adverse effects ; Creatinine ; Cytokines ; Down-regulation ; Down-Regulation - drug effects ; Extrusion ; Glucose metabolism ; Homeostasis ; Inflammation ; Kidney - drug effects ; Kidney - metabolism ; Kidneys ; Lipid metabolism ; Lipids ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Organic Cation Transport Proteins - genetics ; Organic Cation Transport Proteins - metabolism ; Organic Cation Transporter 2 - genetics ; Organic Cation Transporter 2 - metabolism ; Peroxisome proliferator-activated receptors ; PPAR alpha - genetics ; PPAR alpha - metabolism ; Proteins ; Proximal tubules ; Renal function ; Renal Insufficiency - chemically induced ; Renal Insufficiency - metabolism ; Rodents ; Severity of Illness Index ; Signal Transduction - drug effects ; Signal Transduction - genetics ; Solid tumors ; Toxicity ; Transcription factors ; Urine</subject><ispartof>International journal of molecular sciences, 2020-10, Vol.21 (19), p.7416</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533</citedby><cites>FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533</cites><orcidid>0000-0001-9550-6095 ; 0000-0002-0711-5092 ; 0000-0002-7347-1669 ; 0000-0003-0095-4608</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2548688689/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2548688689?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33049997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freitas-Lima, Leandro Ceotto</creatorcontrib><creatorcontrib>Budu, Alexandre</creatorcontrib><creatorcontrib>Arruda, Adriano Cleis</creatorcontrib><creatorcontrib>Perilhão, Mauro Sérgio</creatorcontrib><creatorcontrib>Barrera-Chimal, Jonatan</creatorcontrib><creatorcontrib>Araujo, Ronaldo Carvalho</creatorcontrib><creatorcontrib>Estrela, Gabriel Rufino</creatorcontrib><title>PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellular uptake; elimination of this drug can modulate renal damage. Organic transporters play an important role in the transport of cisplatin into the kidney and organic cations transporter 2 (OCT-2) has been shown to be one of the most important transporters to play this role. On the other hand, multidrug and toxin extrusion 1 (MATE-1) transporter is the main protein that mediates the extrusion of cisplatin into the urine. Cisplatin nephrotoxicity has been shown to be enhanced by increased OCT-2 and/or reduced MATE-1 activity. Peroxisome proliferator-activated receptor alpha (PPAR-α) is the transcription factor which controls lipid metabolism and glucose homeostasis; it is highly expressed in the kidneys and interacts with both MATE-1 and OCT-2. Considering the above, we treated wild-type and PPAR-α knockout mice with cisplatin in order to evaluate the severity of nephrotoxicity. Cisplatin induced renal dysfunction, renal inflammation, apoptosis and tubular injury in wild-type mice, whereas PPAR-α deletion protected against these alterations. Moreover, we observed that cisplatin induced down-regulation of organic transporters MATE-1 and OCT-2 and that PPAR-α deletion restored the expression of these transporters. In addition, PPAR-α knockout mice at basal state showed increased MATE-1 expression and reduced OCT-2 levels. Here, we show for the first time that PPAR-α deletion protects against cisplatin nephrotoxicity and that this protection is via modulation of the organic transporters MATE-1 and OCT-2.</description><subject>Ablation</subject><subject>Animals</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Binding sites</subject><subject>Biomarkers</subject><subject>Cations</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Cisplatin - adverse effects</subject><subject>Creatinine</subject><subject>Cytokines</subject><subject>Down-regulation</subject><subject>Down-Regulation - drug effects</subject><subject>Extrusion</subject><subject>Glucose metabolism</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Kidneys</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Organic Cation Transport Proteins - genetics</subject><subject>Organic Cation Transport Proteins - metabolism</subject><subject>Organic Cation Transporter 2 - genetics</subject><subject>Organic Cation Transporter 2 - metabolism</subject><subject>Peroxisome proliferator-activated receptors</subject><subject>PPAR alpha - genetics</subject><subject>PPAR alpha - metabolism</subject><subject>Proteins</subject><subject>Proximal tubules</subject><subject>Renal function</subject><subject>Renal Insufficiency - chemically induced</subject><subject>Renal Insufficiency - metabolism</subject><subject>Rodents</subject><subject>Severity of Illness Index</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - genetics</subject><subject>Solid tumors</subject><subject>Toxicity</subject><subject>Transcription factors</subject><subject>Urine</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVkdtq3DAQhkVpaI53vS6C3taJjpZ1E1i2mwNkuyH4Xsi2vNHilRxJLt3HyovkmeJkk2ULAzPwf_wzww_Ad4zOKZXowq7WkWAsBcP5F3CEGSEZQrn4ujcfguMYVwgRSrj8Bg4pRUxKKY6Au7-fPGQvz_C36Uyy3sFJSsYNOpkIpzb2nU7WwT-mfww--X-2tmkDqw2c-2Z415bwwTjdwUVYamdrWAbtYu9DMiHC-aScZRhq18DFtMzIKThodRfN2Uc_AeXVrJzeZHeL69vp5C6rGSYpE01lWiY4kryuKiy5MZxh1FKBBeWFlA0pasFyxFjOqTZFjmhbSZrzgjFO6Qm43Nr2Q7U2TW1cCrpTfbBrHTbKa6v-V5x9VEv_VwlekJwVo8HPD4PgnwYTk1r5IYxvRkU4K_JiLDlSv7ZUHXyMwbS7DRipt3DUfjgj_mP_qh38mQZ9BeQBiwE</recordid><startdate>20201008</startdate><enddate>20201008</enddate><creator>Freitas-Lima, Leandro Ceotto</creator><creator>Budu, Alexandre</creator><creator>Arruda, Adriano Cleis</creator><creator>Perilhão, Mauro Sérgio</creator><creator>Barrera-Chimal, Jonatan</creator><creator>Araujo, Ronaldo Carvalho</creator><creator>Estrela, Gabriel Rufino</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9550-6095</orcidid><orcidid>https://orcid.org/0000-0002-0711-5092</orcidid><orcidid>https://orcid.org/0000-0002-7347-1669</orcidid><orcidid>https://orcid.org/0000-0003-0095-4608</orcidid></search><sort><creationdate>20201008</creationdate><title>PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2</title><author>Freitas-Lima, Leandro Ceotto ; Budu, Alexandre ; Arruda, Adriano Cleis ; Perilhão, Mauro Sérgio ; Barrera-Chimal, Jonatan ; Araujo, Ronaldo Carvalho ; Estrela, Gabriel Rufino</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ablation</topic><topic>Animals</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Binding sites</topic><topic>Biomarkers</topic><topic>Cations</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Cisplatin - adverse effects</topic><topic>Creatinine</topic><topic>Cytokines</topic><topic>Down-regulation</topic><topic>Down-Regulation - drug effects</topic><topic>Extrusion</topic><topic>Glucose metabolism</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Kidneys</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Organic Cation Transport Proteins - genetics</topic><topic>Organic Cation Transport Proteins - metabolism</topic><topic>Organic Cation Transporter 2 - genetics</topic><topic>Organic Cation Transporter 2 - metabolism</topic><topic>Peroxisome proliferator-activated receptors</topic><topic>PPAR alpha - genetics</topic><topic>PPAR alpha - metabolism</topic><topic>Proteins</topic><topic>Proximal tubules</topic><topic>Renal function</topic><topic>Renal Insufficiency - chemically induced</topic><topic>Renal Insufficiency - metabolism</topic><topic>Rodents</topic><topic>Severity of Illness Index</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - genetics</topic><topic>Solid tumors</topic><topic>Toxicity</topic><topic>Transcription factors</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freitas-Lima, Leandro Ceotto</creatorcontrib><creatorcontrib>Budu, Alexandre</creatorcontrib><creatorcontrib>Arruda, Adriano Cleis</creatorcontrib><creatorcontrib>Perilhão, Mauro Sérgio</creatorcontrib><creatorcontrib>Barrera-Chimal, Jonatan</creatorcontrib><creatorcontrib>Araujo, Ronaldo Carvalho</creatorcontrib><creatorcontrib>Estrela, Gabriel Rufino</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freitas-Lima, Leandro Ceotto</au><au>Budu, Alexandre</au><au>Arruda, Adriano Cleis</au><au>Perilhão, Mauro Sérgio</au><au>Barrera-Chimal, Jonatan</au><au>Araujo, Ronaldo Carvalho</au><au>Estrela, Gabriel Rufino</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-10-08</date><risdate>2020</risdate><volume>21</volume><issue>19</issue><spage>7416</spage><pages>7416-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellular uptake; elimination of this drug can modulate renal damage. Organic transporters play an important role in the transport of cisplatin into the kidney and organic cations transporter 2 (OCT-2) has been shown to be one of the most important transporters to play this role. On the other hand, multidrug and toxin extrusion 1 (MATE-1) transporter is the main protein that mediates the extrusion of cisplatin into the urine. Cisplatin nephrotoxicity has been shown to be enhanced by increased OCT-2 and/or reduced MATE-1 activity. Peroxisome proliferator-activated receptor alpha (PPAR-α) is the transcription factor which controls lipid metabolism and glucose homeostasis; it is highly expressed in the kidneys and interacts with both MATE-1 and OCT-2. Considering the above, we treated wild-type and PPAR-α knockout mice with cisplatin in order to evaluate the severity of nephrotoxicity. Cisplatin induced renal dysfunction, renal inflammation, apoptosis and tubular injury in wild-type mice, whereas PPAR-α deletion protected against these alterations. Moreover, we observed that cisplatin induced down-regulation of organic transporters MATE-1 and OCT-2 and that PPAR-α deletion restored the expression of these transporters. In addition, PPAR-α knockout mice at basal state showed increased MATE-1 expression and reduced OCT-2 levels. Here, we show for the first time that PPAR-α deletion protects against cisplatin nephrotoxicity and that this protection is via modulation of the organic transporters MATE-1 and OCT-2.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33049997</pmid><doi>10.3390/ijms21197416</doi><orcidid>https://orcid.org/0000-0001-9550-6095</orcidid><orcidid>https://orcid.org/0000-0002-0711-5092</orcidid><orcidid>https://orcid.org/0000-0002-7347-1669</orcidid><orcidid>https://orcid.org/0000-0003-0095-4608</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-10, Vol.21 (19), p.7416
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7582648
source Publicly Available Content Database; PubMed Central
subjects Ablation
Animals
Antineoplastic Agents - adverse effects
Apoptosis
Apoptosis - drug effects
Apoptosis - genetics
Binding sites
Biomarkers
Cations
Chemotherapy
Cisplatin
Cisplatin - adverse effects
Creatinine
Cytokines
Down-regulation
Down-Regulation - drug effects
Extrusion
Glucose metabolism
Homeostasis
Inflammation
Kidney - drug effects
Kidney - metabolism
Kidneys
Lipid metabolism
Lipids
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Organic Cation Transport Proteins - genetics
Organic Cation Transport Proteins - metabolism
Organic Cation Transporter 2 - genetics
Organic Cation Transporter 2 - metabolism
Peroxisome proliferator-activated receptors
PPAR alpha - genetics
PPAR alpha - metabolism
Proteins
Proximal tubules
Renal function
Renal Insufficiency - chemically induced
Renal Insufficiency - metabolism
Rodents
Severity of Illness Index
Signal Transduction - drug effects
Signal Transduction - genetics
Solid tumors
Toxicity
Transcription factors
Urine
title PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PPAR-%CE%B1%20Deletion%20Attenuates%20Cisplatin%20Nephrotoxicity%20by%20Modulating%20Renal%20Organic%20Transporters%20MATE-1%20and%20OCT-2&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Freitas-Lima,%20Leandro%20Ceotto&rft.date=2020-10-08&rft.volume=21&rft.issue=19&rft.spage=7416&rft.pages=7416-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21197416&rft_dat=%3Cproquest_pubme%3E2548688689%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-7dbef475095cbb195ee5410f371735899d28c746044653ae8603fb9365844533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2548688689&rft_id=info:pmid/33049997&rfr_iscdi=true